Scholarlink

Background <p>Intestinal ischemia-reperfusion (I/R) injury is a severe pathological condition characterized by disruption of the mucosal barrier, immune dysregulation, and gut microbiota imbalance. However, whether the gut microbiota regulates immune homeostasis and mucosal repair through arginine metabolism remains unclear.</p> Methods <p>We employed antibiotic-treated and fecal microbiota transplantation (FMT) mouse models, MNK-3 cells, metabolomics, arginine supplementation, and CASTOR1 knockout mice to evaluate intestinal barrier integrity, inflammatory responses, and signaling pathways following I/R injury.</p> Results <p>I/R injury induced significant microbial dysbiosis and decreased fecal arginine levels. FMT demonstrated that microbial alterations reshaped arginine metabolism in recipient mice. Arginine supplementation restored tight junction protein expression, downregulated pro-inflammatory cytokines, enhanced interleukin (IL)-22 secretion, and suppressed IL-17 upregulation. Mechanistically, arginine activated mTORC1 signaling via CASTOR1, thereby promoting IL-22 production, whereas CASTOR1 deficiency or mTORC1 inhibition markedly impaired its protective effects.</p> Conclusions <p>The gut microbiota functions as an upstream regulator of arginine metabolism during I/R injury. Arginine confers immunoprotection by activating the CASTOR1–mTORC1–ILC3 axis, enhancing cytokine secretion and promoting mucosal repair. These findings reveal a novel microbiota–metabolism–immunity interplay and suggest nutrient-sensing pathways as promising therapeutic targets in intestinal injury.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Gut microbiota-derived arginine metabolism mitigates intestinal ischemia-reperfusion injury

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月4日

查看全文
  • Xiaoxi Li,
  • Min Hou,
  • Jipeng Lyu,
  • Xiangzhen Min,
  • Xiaoxia Han,
  • Xinrun Wang,
  • Zhenzhen Liu,
  • Yufang Leng

摘要

Background

Intestinal ischemia-reperfusion (I/R) injury is a severe pathological condition characterized by disruption of the mucosal barrier, immune dysregulation, and gut microbiota imbalance. However, whether the gut microbiota regulates immune homeostasis and mucosal repair through arginine metabolism remains unclear.

Methods

We employed antibiotic-treated and fecal microbiota transplantation (FMT) mouse models, MNK-3 cells, metabolomics, arginine supplementation, and CASTOR1 knockout mice to evaluate intestinal barrier integrity, inflammatory responses, and signaling pathways following I/R injury.

Results

I/R injury induced significant microbial dysbiosis and decreased fecal arginine levels. FMT demonstrated that microbial alterations reshaped arginine metabolism in recipient mice. Arginine supplementation restored tight junction protein expression, downregulated pro-inflammatory cytokines, enhanced interleukin (IL)-22 secretion, and suppressed IL-17 upregulation. Mechanistically, arginine activated mTORC1 signaling via CASTOR1, thereby promoting IL-22 production, whereas CASTOR1 deficiency or mTORC1 inhibition markedly impaired its protective effects.

Conclusions

The gut microbiota functions as an upstream regulator of arginine metabolism during I/R injury. Arginine confers immunoprotection by activating the CASTOR1–mTORC1–ILC3 axis, enhancing cytokine secretion and promoting mucosal repair. These findings reveal a novel microbiota–metabolism–immunity interplay and suggest nutrient-sensing pathways as promising therapeutic targets in intestinal injury.